LEFLORE TECHNOLOGIES LLC
Brandon, MS · Biotech
Biopolymer-stabilized VEGF fusion protein for therapeutic angiogenesis to restore renal microvasculature
- Grants
- $5.0M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Preclinical Trial of Therapeutic Angiogenesis Plus Angioplasty and Stenting for Renal Vascular Disease | $216,429 | |
| Federal grant | Department of Health and Human Services · Phase I · A Preclinical Trial of Therapeutic Angiogenesis Plus Angioplasty and Stenting for Renal Vascular Disease | $216,429 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Renal Therapeutic Angiogenesis Using the Novel Biologic ELP-VEGF | $876,494 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Renal Therapeutic Angiogenesis Using the Novel Biologic ELP-VEGF | $1,837,288 | |
| Federal grant | Department of Health and Human Services · Phase II · Renal Therapeutic Angiogenesis Using the Novel Biologic ELP-VEGF | $960,794 | |
| Federal grant | Department of Health and Human Services · Phase II · Renal Therapeutic Angiogenesis Using the Novel Biologic ELP-VEGF | $856,297 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1320 | OASIS PHARMACEUTICALS, LLC | — | — |
| 1321 | DRIVE THERAPEUTICS, L.L.C. | — | — |
| 1322 | Morphic Therapeutic | — | — |
| 1323 | LEFLORE TECHNOLOGIES LLC | — | — |
| 1324 | NRG Therapeutics | — | — |
| 1325 | Senseion Therapeutics, Inc. | — | — |
| 1326 | Sequegenics LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.